New soluble-formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS-antiviral activity.
about
Synergistic antitumor activity of oncolytic reovirus and chemotherapeutic agents in non-small cell lung cancer cellsInhibitors of human immunodeficiency virus type 1 zinc fingers prevent normal processing of gag precursors and result in the release of noninfectious virus particlesDetection of Inhibition of Bovine Viral Diarrhea Virus by Aromatic Cationic MoleculesSynergistic In Vitro Interactions between Alpha Interferon and Ribavirin against Bovine Viral Diarrhea Virus and Yellow Fever Virus as Surrogate Models of Hepatitis C Virus ReplicationDevelopment of a Novel Dicistronic Reporter-Selectable Hepatitis C Virus Replicon Suitable for High-Throughput Inhibitor ScreeningSynthesis, Activity, and Structural Analysis of Novel α-Hydroxytropolone Inhibitors of Human Immunodeficiency Virus Reverse Transcriptase-Associated Ribonuclease HA Synthetic mirror image of kalata B1 reveals that cyclotide activity is independent of a protein receptorApplication of 3D Zernike descriptors to shape-based ligand similarity searchingOxathiin carboxanilide, a potent inhibitor of human immunodeficiency virus reproductionIn vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C proteaseMultiple effects of an anti-human immunodeficiency virus nucleocapsid inhibitor on virus morphology and replication.Inhibition of human rhinovirus-induced cytokine production by AG7088, a human rhinovirus 3C protease inhibitorThe ribavirin analog ICN 17261 demonstrates reduced toxicity and antiviral effects with retention of both immunomodulatory activity and reduction of hepatitis-induced serum alanine aminotransferase levelsBMS-232632, a highly potent human immunodeficiency virus protease inhibitor that can be used in combination with other available antiretroviral agentsIn vitro resistance profile of the human immunodeficiency virus type 1 protease inhibitor BMS-232632Mechanism of action of 1-beta-D-2,6-diaminopurine dioxolane, a prodrug of the human immunodeficiency virus type 1 inhibitor 1-beta-D-dioxolane guanosineExpression and potential role of Fas-associated phosphatase-1 in ovarian cancerPotent efficacy of entecavir (BMS-200475) in a duck model of hepatitis B virus replication.Inhibition of human immunodeficiency virus type 1 transcription and replication by DNA sequence-selective plant lignansK65R mutation of human immunodeficiency virus type 1 reverse transcriptase encodes cross-resistance to 9-(2-phosphonylmethoxyethyl)adenineDiarylsulfones, a new chemical class of nonnucleoside antiviral inhibitors of human immunodeficiency virus type 1 reverse transcriptaseSpecific inhibition of the reverse transcriptase of human immunodeficiency virus type 1 and the chimeric enzymes of human immunodeficiency virus type 1 and type 2 by nonnucleoside inhibitorsAntiviral properties of aminodiol inhibitors against human immunodeficiency virus and proteaseCharacterization of a human immunodeficiency virus type 1 variant with reduced sensitivity to an aminodiol protease inhibitorSusceptibilities of zidovudine-resistant variants of human immunodeficiency virus type 1 to inhibition by acyclic nucleoside phosphonatesMetabolism and in vitro antiretroviral activities of bis(pivaloyloxymethyl) prodrugs of acyclic nucleoside phosphonatesStructure-activity and cross-resistance evaluations of a series of human immunodeficiency virus type-1-specific compounds related to oxathiin carboxanilideEvaluation of reverse transcriptase and protease inhibitors in two-drug combinations against human immunodeficiency virus replicationIdentification of BMS-200475 as a potent and selective inhibitor of hepatitis B virusCharacterization of siamycin I, a human immunodeficiency virus fusion inhibitorHuman immunodeficiency virus type 1 proteinase resistance to symmetric cyclic urea inhibitor analogsNovel mutation (K70E) in human immunodeficiency virus type 1 reverse transcriptase confers decreased susceptibility to 9-[2-(phosphonomethoxy)ethyl]adenine in vitroDiarylsulfones, a novel class of human immunodeficiency virus type 1 integrase inhibitorsImportance of ribosomal frameshifting for human immunodeficiency virus type 1 particle assembly and replication.Antioxidant Activity of Lawsonia inermis Extracts Inhibits Chromium(VI)-Induced Cellular and DNA ToxicityTrust, but verify: on the importance of chemical structure curation in cheminformatics and QSAR modeling researchAn evaluation of the RNase H inhibitory effects of Vietnamese medicinal plant extracts and natural compounds.In vitro resistance study of rupintrivir, a novel inhibitor of human rhinovirus 3C protease.In vitro antiviral activity and single-dose pharmacokinetics in humans of a novel, orally bioavailable inhibitor of human rhinovirus 3C protease.Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitor.
P2860
Q21245717-7E8AF137-D1CF-46F7-BBB6-B8205BD7EAE4Q24681117-8F7C702A-E597-434C-82AE-C26EA061367FQ27477550-57F2359C-3ACC-4FD6-A522-7251E373D948Q27477551-6A3267D9-7A2D-4E9E-AEC5-62BAA712663DQ27478065-C4A8BD94-D2AE-4BC8-BC73-499EFA3A3C44Q27667836-DBA37A8C-CBF1-49B7-9353-6027AB6163C7Q27674170-A227E8DE-2E11-4340-952E-9F0B98D89817Q27998664-6B87E2AC-3D70-4AEF-8028-F20DD2562C22Q28323972-3E2EC531-0DB4-4F71-A7B1-EBEB4DCE642AQ28343611-2F9440DE-A8A1-436A-A787-43B648ACBFB8Q28343701-4A52A300-9285-48B4-87F8-ECEA90D3C246Q28344143-68EA5790-4757-4CCC-9AA9-AD7E8D3DB840Q28344154-EF485E0D-B96E-4DEA-9866-8854BBB0FADEQ28344472-BE6FFE94-CBF3-401A-8CCC-D75901FD0A6AQ28344594-EEA17EB5-03CA-4DB0-9EAC-C1FAABC833F3Q28345240-2BAC877E-771B-4C35-B06D-61E3C868DC07Q28362064-4BB1B473-C5FF-4061-A047-DE708F3DB2B1Q28366818-7C376964-734B-4923-A64D-1707C85BF55DQ28367369-4E0CDB92-1CF7-44FE-9163-693D82851CC1Q28367386-18771519-7185-41EE-A4D1-A9C57CF517BBQ28368023-28B3DCEB-BDF6-45E0-98A8-65E46C159767Q28368032-4AB77F9F-C2BD-47C0-BC22-4BD470CB0289Q28368090-F6256184-756E-4E9C-8BD9-FCBB6D65DA5FQ28368832-1D1D3DFA-851B-403D-B001-4E22AF2D6308Q28369111-B6502663-F287-4946-87FC-3A3A7CD7C1B9Q28378408-450C8FCE-E086-4888-83EE-54075A6C4905Q28378796-474F45F8-4BAD-4184-8505-43C43A9322E6Q28378991-8F77AB88-825B-4078-9823-DE7F91C16900Q28379014-58AA8A30-6606-463E-826B-95AF299B35D4Q28379084-602801B9-8ABA-4812-8F34-C90FD0D94C4DQ28379226-F2E9B607-039B-4CF7-810E-116C08F2E912Q28379249-6334A2E8-C110-488D-B99D-A6263308032AQ28379464-0CBFB188-0E17-4965-B0FD-D907A1EA4280Q28379495-727188F5-8ED5-4369-B30E-9ACF1C560EDDQ28742604-21B17D4A-44E5-4C2D-B56A-A061B6068F90Q28748220-D707C016-2CC1-4548-8C9C-86EADE979129Q30402894-41D21D51-7CFD-478B-B8D0-7F7622905C65Q30443266-7C795FC8-FADB-479A-B6F2-CB04A36D78BAQ30448335-AF01E3FE-7F84-43AE-8823-7AF9045E5768Q30448643-1E23D337-9DC9-413A-B36D-7F95BB5B17A2
P2860
New soluble-formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS-antiviral activity.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
New soluble-formazan assay for ...... s for AIDS-antiviral activity.
@en
New soluble-formazan assay for ...... s for AIDS-antiviral activity.
@nl
type
label
New soluble-formazan assay for ...... s for AIDS-antiviral activity.
@en
New soluble-formazan assay for ...... s for AIDS-antiviral activity.
@nl
prefLabel
New soluble-formazan assay for ...... s for AIDS-antiviral activity.
@en
New soluble-formazan assay for ...... s for AIDS-antiviral activity.
@nl
P2093
P356
P1476
New soluble-formazan assay for ...... s for AIDS-antiviral activity.
@en
P2093
P304
P356
10.1093/JNCI/81.8.577
P407
P577
1989-04-01T00:00:00Z